The global self-monitoring blood glucose devices market, valued at USD 12.59 billion in 2025, is projected to grow at a CAGR of 11.44% and reach USD 33.30 billion by 2034. The market is driven by the increasing prevalence of diabetes, especially type 2, and the rising demand for self-monitoring devices.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Self-monitoring Blood Glucose Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Self-monitoring Blood Glucose Devices Market Revenue and Volume, By Product
8.1.1 Testing Strips
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Continuous Glucose Monitors
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. lancets
8.1.4.1. Market Revenue and Volume Forecast
9.1. Self-monitoring Blood Glucose Devices Market Revenue and Volume, By Application
9.1.1. Type 2 Diabetes
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Type 1 Diabetes
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Gestational Diabetes
9.1.3.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product
10.1.2. Market Revenue and Volume Forecast, By Application
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product
10.1.3.2. Market Revenue and Volume Forecast, By Application
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product
10.1.4.2. Market Revenue and Volume Forecast, By Application
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product
10.2.2. Market Revenue and Volume Forecast, By Application
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product
10.2.3.2. Market Revenue and Volume Forecast, By Application
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product
10.2.4.2. Market Revenue and Volume Forecast, By Application
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product
10.2.5.2. Market Revenue and Volume Forecast, By Application
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product
10.2.6.2. Market Revenue and Volume Forecast, By Application
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product
10.3.2. Market Revenue and Volume Forecast, By Application
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product
10.3.3.2. Market Revenue and Volume Forecast, By Application
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product
10.3.4.2. Market Revenue and Volume Forecast, By Application
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product
10.3.5.2. Market Revenue and Volume Forecast, By Application
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product
10.3.6.2. Market Revenue and Volume Forecast, By Application
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product
10.4.2. Market Revenue and Volume Forecast, By Application
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product
10.4.3.2. Market Revenue and Volume Forecast, By Application
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product
10.4.4.2. Market Revenue and Volume Forecast, By Application
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product
10.4.5.2. Market Revenue and Volume Forecast, By Application
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product
10.4.6.2. Market Revenue and Volume Forecast, By Application
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product
10.5.2. Market Revenue and Volume Forecast, By Application
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product
10.5.3.2. Market Revenue and Volume Forecast, By Application
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product
10.5.4.2. Market Revenue and Volume Forecast, By Application
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Bionime Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. B. Braun Melsungen AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. F. Hoffmann-La Roche Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. LifeScan IP Holdings, LLC
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. PHC Holdings Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Terumo Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Trividia Health, Inc. (Sinocare Inc.)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. ARKRAY, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ypsomed Holding AG
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description